PC World - Oracle on Friday announced plans to buy Phase Forward, which develops software for drug manufacturers, for about US $685 million. The deal is expected to close mid-year. Software News
الذين يشاهدون الموضوع الآن: 2 (0 من الأعضاء و 2 زائر)
قوانين المنتدى
مواقع النشر (المفضلة)